For healthcare professionals only

Research Article

I alpha-hydroxycholecalciferol: a treatment of renal bone disease.

Br Med J 1975; 1 doi: (Published 04 January 1975) Cite this as: Br Med J 1975;1:12
  1. G R Catto,
  2. M MacLeod,
  3. B Pelc,
  4. E Kodicek


    Three patients with chronic renal failure on maintenance haemodialysis have been treated with 1 alpha-hydroxycholecalciferol (1 alpha-OHCC), a synthetic vitamin D analogue. A daily dose of 2 mug by mouth produced a significant increase in both calcium absorption from the gastrointestinal tract and calcium content of bone. Treatment with 1 alpha-OHCC appears to be effective in cases of metabolic bone disease associated with chronic renal failure.